A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.

Clinical trial NCT06447662 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06447662
Sponsor: Pfizer
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Pancreatic Ductal Colorectal Neoplasms Carcinoma, Non-Small-Cell Lung

Start date: 2024-06-27
Primary completion: 2026-10-09
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.